An inhibitor of cancer stem cells, displaying greater than 23-fold selective inhibition of a breast cancer stem cell-like cell line (EC50 = 1.18 µM) over an isogenic control cell line (EC50 = 27.6 µM); alters the expression of genes in the MAPK, NF-κB, and inflammatory cytokine pathways.